Recombinant multi-species ERP29 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ERP29 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a protein which localizes to the lumen of the endoplasmic reticulum (ER). It is a member of the protein disulfide isomerase (PDI) protein family but lacks an active thioredoxin motif, suggesting that this protein does not function as a disulfide isomerase. The canonical protein dimerizes and is thought to play a role in the processing of secretory proteins within the ER. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2016]
The Alternative Names of target: 1200015M03Rik,2810446M09Rik,C12orf8,ERP29,ERp28,ERp29,ERp31,Endoplasmic reticulum resident protein 28 (ERp28),Endoplasmic reticulum resident protein 29,Endoplasmic reticulum resident protein 31 (ERp31),Erp28,Erp29,Erp31,HEL-S-107,PDI-DB,PDI-Db,PDIA9

Target products collectionGo to ERP29 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-SE0187-Ag-1/ GM-Tg-hg-SE0187-Ag-2 Human ERP29 protein Human
GM-Tg-rg-SE0187-Ag-1/ GM-Tg-rg-SE0187-Ag-2 Rat ERP29 protein Rat
GM-Tg-mg-SE0187-Ag-1/ GM-Tg-mg-SE0187-Ag-2 Mouse ERP29 protein Mouse
GM-Tg-cynog-SE0187-Ag-1/ GM-Tg-cynog-SE0187-Ag-2 Cynomolgus/Rhesus macaque ERP29 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-SE0187-Ag-1/ GM-Tg-felg-SE0187-Ag-2 Feline ERP29 protein Feline
GM-Tg-cang-SE0187-Ag-1/ GM-Tg-cang-SE0187-Ag-2 Canine ERP29 protein Canine
GM-Tg-bovg-SE0187-Ag-1/ GM-Tg-bovg-SE0187-Ag-2 Bovine ERP29 protein Bovine
GM-Tg-equg-SE0187-Ag-1/ GM-Tg-equg-SE0187-Ag-2 Equine ERP29 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-SE0187-Ag-1/ GM-Tg-hg-SE0187-Ag-2; GM-Tg-rg-SE0187-Ag-1/ GM-Tg-rg-SE0187-Ag-2;
GM-Tg-mg-SE0187-Ag-1/ GM-Tg-mg-SE0187-Ag-2; GM-Tg-cynog-SE0187-Ag-1/ GM-Tg-cynog-SE0187-Ag-2;
GM-Tg-felg-SE0187-Ag-1/ GM-Tg-felg-SE0187-Ag-2; GM-Tg-cang-SE0187-Ag-1/ GM-Tg-cang-SE0187-Ag-2;
GM-Tg-bovg-SE0187-Ag-1/ GM-Tg-bovg-SE0187-Ag-2; GM-Tg-equg-SE0187-Ag-1/ GM-Tg-equg-SE0187-Ag-2
Products Name ERP29 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name ERP29
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine ERP29 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.